Chen, M., Ge, Y., Dworkin, L. and Gong, R. 2025. Glycogen synthase kinase (GSK) 3beta hyperactivity impairs glomerular podocyte insulin signaling via IRS1 modulation in diabetic kidney disease. Translation: The University of Toledo Journal of Medical Sciences. 13, S3 (Jun. 2025). DOI:https://doi.org/10.46570/utjms-2025-1352.